Central precocious puberty: Short-term comparative data of treatment with monthly or long-acting three months depot triptorelin

Silvano Bertelloni, Alessandra Cassio, Teresa Arrigo, Malgorzata Wasniewska, Fiorella Galluzzi, Silvia Einaudi, Marco Cappa, Giuseppe Chiumello, Milva Bal, Stephania Losi, Giampiero I. Baroncelli, Giuseppe Saggese

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Depot GnRH analogs represent the treatment of choice for central precocious puberty (CPP). Few data are available on pubertal suppression for the newer 3-month formulations. In addition, comparison between the monthly and quarterly tripotorelin depot is lacking. Aim: To assess the efficacy on pituitary and gonadal suppression of triptorelin 11.25 mg/3 months in girls with CPP and to compare the new formulation with triptorelin 3.75 mg/28 days. Patients and Methods: Thirty-five girls with clinical and endocrine diagnosis of CPP (puberty onset

Original languageEnglish
Pages (from-to)297-305
Number of pages9
JournalJournal of Pediatric Endocrinology and Metabolism
Volume20
Issue numberSUPPL. 2
Publication statusPublished - Feb 2007

Keywords

  • Central precocious puberty
  • GnRH analogs
  • Monthly triptorelin depot
  • Puberty suppression
  • Quarterly triptorelin depot

ASJC Scopus subject areas

  • Endocrinology
  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Central precocious puberty: Short-term comparative data of treatment with monthly or long-acting three months depot triptorelin'. Together they form a unique fingerprint.

Cite this